NPPA

India’s epidemiological transition: the triple-burden of diseases calls for broader thinking as legislative price-control, entails…

Surbhi Premi, Joint Director, Lakshmikumaran & Sridharan advises the healthcare sector to carefully analyse NPPA orders to fix…

In India's price sensitive market, domestic stent manufacturers have fared well and are now capturing global markets By Raelene…

Regulation is both intention as well as implementation. The former remains an empty promise if the latter cannot keep up with the…

A nine-member committee was set up five months ago to suggest the scope of profit margins on medicines and consumables